Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

µÎ°³ÇϾÇÀå¾Ö ȯÀÚÀÇ ¾È¸é°ñ ºñ´ëĪ¼º¿¡ °üÇÑ ¹æ»ç¼±»çÁø»ó ºñ±³ºÐ¼®

RADIOGRAPHIC COMPARATIVE STUDY OF FACIAL SKELETAL ASYMMETRY IN CRANIOMANDIBULAR DISORDER PATIENTS

Ä¡°ú¹æ»ç¼± 1994³â 24±Ç 2È£ p.291 ~ 304
¹Ú¿ø±æ, ÃÖÀÇȯ, ÀåÇö¼±,
¼Ò¼Ó »ó¼¼Á¤º¸
¹Ú¿ø±æ (  ) - Á¶¼±´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­¾Ç¾È¸é¹æ»ç¼±ÇÐ
ÃÖÀÇȯ (  ) - Á¶¼±´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­¾Ç¾È¸é¹æ»ç¼±ÇÐ
ÀåÇö¼± (  ) - Á¶¼±´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­¾Ç¾È¸é¹æ»ç¼±ÇÐ

Abstract

ÀúÀÚ´Â ÃøµÎÇϾǰüÀý µ¿Åë, ÀâÀ½ ¹× °³±¸Á¦ÇÑ µîÀÇ Áõ»óÀ» ÁÖ¼Ò·Î ÇÏ¿© Á¶¼±´ëÇб³ ºÎ¼Ó
Ä¡°úº´¿ø¿¡ ³»¿øÇÑ µÎ°³ÇϾÇÀå¾Ö ȯÀÚ 50¸í(Æò±Õ ³ªÀÌ:31.04¼¼)À» ȯÀÚ±ºÀ¸·Î ÇÏ°í µÎ°³ÇϾÇ
Àå¾ÖÀÇ º´·Â ¹× ÇöÁõÀÌ ¾øÀ¸¸ç, Á¤»óÀûÀÎ ±³ÇÕ»óŸ¦ º¸ÀÌ°í ±³Á¤Ä¡·áµîÀ» ¿äÇÏÁö ¾ÊÀº, Á¤
»ó ¾È¸ð¸¦ °¡Áø Á¶¼±´ëÇб³ Ä¡°ú´ëÇÐ Çлý 40¸í(Æò±Õ ³ªÀÌ:24.58¼¼)À» ´ëÁ¶±ºÀ¸·Î ÇÏ¿© Ç¥ÁØ
È­µÈ Á¶°ÇÇÏ¿¡¼­ ÃÔ¿µÇÏ¿© ¾ò¾îÁø ÈÄÀü¹æ µÎºÎ±Ô°Ý ¹æ»ç¼±»çÁø°ú µÎºÎÃà¹æÇâ ¹æ»ç¼± »çÁøÀ»
°èÃø ºÐ¼®ÇÏ¿© ´ÙÀ½°ú °°Àº °á°ú¸¦ ¾ò¾ú´Ù.
1. ÈÄÀü¹æ µÎºÎ±Ô°Ý ¹æ»ç¼±»ó, ¹Øº¯ÀÇ Â÷¿¡ À־ ¡âCg-Go-ClÀÇ ´ëÁ¶±º¿¡¼­ 3.35§®, ȯ
ÀÚ±º¿¡¼­ 4.51§®¿´À¸¸ç(P<0.05), ¡âCg-Zy-GoÀÇ ´ëÁ¶±º¿¡¼­ 1.83§®, ȯÀÚ±º¿¡¼­ 3.27§®¿´´Ù
(P<0.001).
2. ÈÄÀü¹æ µÎºÎ±Ô°Ý¹æ»ç¼±»ó,³ôÀÌÀÇ Â÷¿¡ À־ ¡âCg-Go-ClÀÇ ´ëÁ¶±º¿¡¼­ 131.85§®, ȯ
ÀÚ±º¿¡¼­ 188.45§®¿´À¸¸ç(P<0.05), ¡âCg-Zy-GoÀÇ ´ëÁ¶±º 1.58§®, ȯÀÚ±º¿¡¼­ 2.68§®¿´´Ù
(P<0.001).
3. ÈÄÀü¹æ µÎºÎ±Ô°Ý ¹æ»ç¼±»ó, ¸éÀûÀÇ Â÷¿¡ À־ ¡âCg-Go-ClÀÇ ´ëÁ¶±º¿¡¼­ 120.76§±,
ȯÀÚ±º¿¡¼­ 185.49§±¿´À¸¸ç(P<0.05), ¡âCg-Zy-GoÀÇ ´ëÁ¶±º¿¡¼­ 2.29§±, ȯÀÚ±º¿¡¼­ 3.37§±¿´
´Ù(p<0.05).
4. µÎºÎÃà¹æÇâ ¹æ»ç¼±»ó, ¹Øº¯ÀÇ Â÷¿¡ À־ ¡âMr-Cl-IaÀÇ ´ëÁ¶±º¿¡¼­ 1.50§®, ȯÀÚ±º¿¡
¼­ 2.35§®¿´À¸¸ç (P<0.05), ¡âMr-Cm-IaÀÇ ´ëÁ¶±º¿¡¼­ 1.75§®, ȯÀÚ±º¿¡¼­ 3.17§®¿´À¸¸ç
(P<0.05), ¡âMr-Go-IaÀÇ ´ëÁ¶±º¿¡¼­ 1.96§®, ȯÀÚ±º¿¡¼­ 3.24§®¿´À¸¸ç(P<0.001), ¡â
Mr-Cp-CoÀÇ ´ëÁ¶±º¿¡¼­ 1.74§®, ȯÀÚ±º¿¡¼­ 2.73§®¿´´Ù(P<0.05).
5. µÎºÎÃà¹æÇâ ¹æ»ç¼±»çÁø»ó, ³ôÀÌÀÇ Â÷¿¡ À־ ¡âMr-Cp-IaÀÇ ´ëÁ¶±º¿¡¼­ 1.68§®, ȯÀÚ
±º¿¡¼­ 2.46§®¿´À¸¸ç (P<0.05), ¡âMr-Cl-IaÀÇ ´ëÁ¶±º¿¡¼­ 2.38§®, ȯÀÚ±º¿¡¼­ 3.74§® ¿´À¸¸ç
(P<0.05), ¡âMr-Co-laÀÇ ´ëÁ¶±º¿¡¼­ 1.63§®, ȯÀÚ±º¿¡¼­ 2.8%§®¿´À¸¸ç(P<0.05), ¡â
Mr-Cm-IaÀÇ ´ëÁ¶±º¿¡¼­ 1.45§®, ȯÀÚ±º¿¡¼­ 3.12§®¿´´Ù(P<0.001).
6. µÎºÎÃà¹æÇâ ¹æ»ç¼±»ó, ¸éÀûÀÇ Â÷¿¡ À־´Â ¡âMr-Cp-IaÀÇ ´ëÁ¶±º¿¡¼­ 73.17§±, ȯÀÚ
±º¿¡¼­ 110.16§±¿´À¸¸ç(P<0.05), ¡âMr-Cl-IaÀÇ ´ëÁ¶±º¿¡¼­ 105.09§±, ȯÀÚ±º¿¡¼­ 180.87§±¿´
À¸¸ç (P<0.001), ¡âMr-Co-IaÀÇ ´ëÁ¶±º¿¡¼­ 103.31§±, ȯÀÚ±º¿¡¼­ 148.48§±¿´À¸¸ç(P<0.05), ¡â
Mr-Cm-IaÀÇ ´ëÁ¶±º¿¡¼­ 97.01§±, ȯÀÚ±º¿¡¼­ 167.83§±¿´À¸¸ç(P<0.05), ¡âMr-Go-laÀÇ ´ëÁ¶
±º¿¡¼­ 104.24§±, ȯÀÚ±º¿¡¼­ 205.90§±¿´´Ù(P<0.05).
ÀÌ»óÀÇ °á°ú¸¦ Á¾ÇÕÇØ º¼ ¶§ ¹æ»ç¼± »çÁø»ó¿¡¼­ ¾È¸ðºñ´ëĪÀÇ ºÐ¼®Àº µÎ°³ÇϾÇÀå¾Ö¸¦ Áø
´ÜÇÏ´Â À¯¿ëÇÑ ¹æ¹ýÀÌ µÉ ¼ö ÀÖ´Ù°í »ç·áµÈ´Ù.
#ÃÊ·Ï#
The purpose of this study was to analyze the facial asymmetry of the patients with
the craniomandibular disorder.
In this study, 50 patients, who have joint clicking and pain, mouth opening limitation,
and 40 dental students, Chosun University, who did not posses any restoration and
orthodontic treatment, joint clicking and pain, mouth opening limitation, were selected as
the control group.
Both the control group and the patient group were wakened skull P-A,
submento-vertex radiogram by standized methods. After that, the deviation and facial
asymmetry were measured and analyzed.
The results of the this study were as follows:
1. In the Skull P-A radiogram, the width difference of control group and patient group
measured that the ¡âCg-Go-Cl: control group were 3.35§®, patient group were 4.51§®
(P<0.05), the ¡âCg-Zy-Go: control group were 1.83§®, patient group were 3.27§®
(P<0.001).
2. In the Skull P-A radiogram, the height difference of control group and patient
group measured that the ¡âCg-Go-Cl: control group were 131.85§®, patient group were
188.45§®(P<0.05), the ¡âCg-Zy-Go: control group were 1.58§®, patient group were 2.68§®
(P<0.001).
3. In the Skull P-A radiogram, the area difference of control group and patient group
measured that the ¡âCg-Go-Cl: control group were 120.76§±, patient group were 185.49§±
(P<0.05), the ¡âCg-Zy-Go: control group were 2.29§±, patient group were 3.37§±(p<0.05).
4. In the submento-vertex radiogram, the width difference of control group and patient
group measured that the ¡âMr-Cl-Ia: control group were 1.50§®, patient group were 2.35
§®(P<0.05), the ¡âMr-Cm-Ia: control group were 1.75§®, patient group were 3.17§®
(P<0.05), the ¡âMr-Go-Ia: control group were 1.96§®, patient group were 3.24§®
(P<0.001), the ¡âMr-Cp-Co: control group were 1.74§®, patient group were 2.73§®
(P<0.05).
5. In the submento-vertex radiogram, the height difference of control group and
patient group measured that the ¡âMr-Cp-Ia: control group were 1.68§®, patient group
were 2.46§®(P<0.05), the ¡âMr-Cl-Ia: control group were 2.38§®, patient group were 3.74
§®(P<0.05), the ¡âMr-Co-Ia: control group were 1.63§®, patient group were 2.80§®
(P<0.05), the ¡âMr-Cm-Ia: control group were 1.45§®, patient group were 3.12§®
(P<0.001).
6. In the submento-vertex radiogram, the area difference of control group and patient
group measured that the ¡âMr-Cp-Ia: control group were 73.17§±, patient group were
110.16§±(P<0.05), the ¡âMr-Cl-Ia: control group were 105.09§±, patient group were 180.87
§±(P<0.001), the ¡âMr-Co-Ia: control group were 103.31§±, patient group were 148.48§±
(P<0.05), the ¡âMr-Cm-Ia: control group were 97.01§±, patient group were 167.83 §±
(P<0.05), the ¡âMr-Go-Ia: control group were 104.24§±, patient group were 205.90§±
(P<0.05).

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸